TY - JOUR AU - Delaney, M. AU - Wendel, S. AU - Bercovitz, R. S. PY - 2016 DA - 2016// TI - Transfusion reactions: prevention, diagnosis, and treatment JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(15)01313-6 DO - 10.1016/S0140-6736(15)01313-6 ID - Delaney2016 ER - TY - JOUR AU - Stanworth, S. J. AU - Navarrete, C. AU - Estcourt, L. AU - Marsh, J. PY - 2015 DA - 2015// TI - Platelet refractoriness--practical approaches and ongoing dilemmas in patient management JO - Br J Haematol VL - 171 UR - https://doi.org/10.1111/bjh.13597 DO - 10.1111/bjh.13597 ID - Stanworth2015 ER - TY - JOUR AU - Kim, E. S. PY - 2016 DA - 2016// TI - Lusutrombopag: First global approval JO - Drugs VL - 76 UR - https://doi.org/10.1007/s40265-015-0525-4 DO - 10.1007/s40265-015-0525-4 ID - Kim2016 ER - TY - BOOK PY - 2015 DA - 2015// TI - Shionogi receives marketing and manufacturing approval in Japan for MULPLETA® tablets 3mg for improvement of thrombocytopenia [media release] ID - ref4 ER - TY - BOOK AU - US, F. D. A. PY - 2018 DA - 2018// TI - Highlights of prescribing information. MULPLETA® (lusutrombopag tablets) for oral use initial Approval 2018 [media release] ID - US2018 ER - TY - JOUR AU - Chotinantakul, K. AU - Leeanansaksiri, W. PY - 2012 DA - 2012// TI - Hematopoietic stem cell development, niches, and signaling pathways JO - Bone Marrow Res VL - 2012 UR - https://doi.org/10.1155/2012/270425 DO - 10.1155/2012/270425 ID - Chotinantakul2012 ER - TY - BOOK PY - 2015 DA - 2015// TI - Mulpleta® (lusutrombopag) tablets; Japanese prescribing information (in Japanese) ID - ref7 ER - TY - JOUR AU - Kinjo, N. AU - Kawanaka, H. AU - Akahoshi, T. PY - 2014 DA - 2014// TI - Portal vein thrombosis in liver cirrhosis JO - World J Hepatol VL - 6 UR - https://doi.org/10.4254/wjh.v6.i2.64 DO - 10.4254/wjh.v6.i2.64 ID - Kinjo2014 ER - TY - JOUR AU - Kotani, S. AU - Kohge, N. AU - Tsukano, K. PY - 2017 DA - 2017// TI - Avoidance of platelet transfusion with readministration of lusutrombopag before radiofrequency ablation in hepatocellular carcinoma: a case report JO - Nihon Shokakibyo Gakkai Zasshi VL - 114 ID - Kotani2017 ER - TY - JOUR AU - Sato, S. AU - Miyake, T. AU - Kataoka, M. PY - 2017 DA - 2017// TI - Efficacy of repeated lusutrombopag administration for thrombocytopenia in a patient scheduled for invasive hepatocellular carcinoma treatment JO - Intern Med VL - 56 UR - https://doi.org/10.2169/internalmedicine.8791-16 DO - 10.2169/internalmedicine.8791-16 ID - Sato2017 ER - TY - JOUR AU - Afdhal, N. H. AU - Giannini, E. G. AU - Tayyab, G. PY - 2012 DA - 2012// TI - Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1110709 DO - 10.1056/NEJMoa1110709 ID - Afdhal2012 ER -